. 2010 Jul 9;87(1):75–89. doi: 10.1016/j.ajhg.2010.06.006

Table 3.

Distribution of Breakpoint Positions in Germ Cell Lines and in Cancer Cell Lines

Loci	Breakpoints	Samples	Number	Mean	Median	Mann-Whitney U test	Standard Deviation	Squared-Ranks Test	Skewness	Kurtosis
PARK2	upstream breakpoints	patients with AR-JP	162	162,632,436	162,648,608	p = 0.36	203,951	p < 0.0001	−1.21	4.01
	upstream breakpoints	cancer cell lines	32	162,549,884	162,626,524	p = 0.36	401,285	p < 0.0001	−0.30	−0.37
	downstream breakpoints	patients with AR-JP	162	162,462,592	162,515,588	p = 0.53	210,775	p < 0.0001	−1.35	3.03
	downstream breakpoints	cancer cell lines	32	162,405,816	162,440,014	p = 0.53	389,800	p < 0.0001	−0.38	−0.56
DMD	upstream breakpoints	patients with DMD/BMD	197	32,151,340	31,967,332	p = 0.49	405,283	p = 0.99	0.73	−0.93
	upstream breakpoints	cancer cell lines	6	32,063,805	31,932,249	p = 0.49	518,968	p = 0.99	1.57	2.75
	downstream breakpoints	patients with DMD/BMD	197	31,969,561	31,796,456	p = 0.78	402,560	p = 0.81	0.80	−0.71
	downstream breakpoints	cancer cell lines	6	31,900,988	31,816,981	p = 0.78	600,593	p = 0.81	1.12	2.25